Citizens Maintains Market Outperform on LeonaBio, Lowers Price Target to $17

Benzinga · 3d ago
Citizens analyst Jason N. Butler maintains LeonaBio (NASDAQ:LONA) with a Market Outperform and lowers the price target from $18 to $17.